CVS Health Corporation (CVS)
NYSE: CVS · Real-Time Price · USD
71.29
-0.19 (-0.27%)
At close: Mar 23, 2026, 4:00 PM EDT
71.18
-0.11 (-0.15%)
Pre-market: Mar 24, 2026, 8:05 AM EDT

CVS Health Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Quarter
Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021Q3 2021Q2 2021Q1 2021
Period Ending
Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Sep '23 Jun '23 Mar '23 Dec '22 Sep '22 Jun '22 Mar '22 Dec '21 Sep '21 Jun '21 Mar '21
105,693102,87198,91594,58897,71095,42891,23488,43793,81389,76488,92185,27883,84681,15980,63676,82676,60473,79472,61669,097
Revenue Growth (YoY)
8.17%7.80%8.42%6.96%4.15%6.31%2.60%3.70%11.89%10.60%10.27%11.00%9.45%9.98%11.04%11.19%10.14%10.05%11.13%3.51%
Cost of Revenue
92,12689,06585,32280,19284,81182,87077,85175,87679,93776,18775,31871,90369,98767,76666,78063,43262,88061,09259,42156,598
Gross Profit
13,56713,80613,59314,39612,89912,55813,38312,56113,87613,57713,60313,37513,85913,39313,85613,39413,72412,70213,19512,499
Selling, General & Admin
11,45511,28811,21211,02210,52110,55710,33810,29010,5039,8769,8739,58010,0899,6129,1879,32410,0209,2108,8698,922
Other Operating Expenses
-5,725--101,169---11496-3491862,740-4431,358431--
Total Operating Expenses
11,45517,01311,21211,02210,53111,72610,33810,29010,5039,88710,3699,23110,27512,3529,1879,76711,3789,6418,8698,922
Operating Income
2,112-3,2072,3813,3742,3688323,0452,2713,3733,6903,2343,4463,618-3,9194,6693,5452,3463,0614,3263,577
Interest Expense
787784-763-785758752-732-716-690-693-686-589-552-566-583-586-608-602-636-657
Other Non-Operating Income (Expense)
29509-29-2851625-24-25-22-22-22-22-43-41-43-42-127-412-45-50
Total Non-Operating Income (Expense)
8161,293-792-8131,274777-756-741-712-715-708-611-595-607-626-628-735-1,014-681-707
Pretax Income
1,354-3,4821,6472,6172,1261052,3371,5802,7053,0192,5702,8793,150-4,4444,1293,0011,6872,1453,7352,970
Provision for Income Taxes
-1,56950863483550334569456658754656737818-1,0451,090646300558944746
Net Income
2,943-3,9751,0211,7791,644871,7701,1132,0462,2611,9012,1362,334-3,4063,0292,3541,3971,5982,7832,223
Minority Interest in Earnings
-20-15-8-3-21-16-2-111413-6-2-7-10-1-10-11-8-1
Net Income to Common
2,943-3,9751,0211,7791,644871,7701,1132,0462,2611,9012,1362,334-3,4063,0292,3541,3971,5982,7832,223
Net Income Growth
79.02%--42.32%59.84%-19.65%-96.15%-6.89%-47.89%-12.34%--37.24%-9.26%67.07%-8.84%5.89%43.58%30.56%-6.45%10.76%
Shares Outstanding (Basic)
1,2701,2691,2661,2611,2591,2591,2561,2601,2881,2871,2831,2831,3101,3151,3131,3121,3221,3211,3191,313
Shares Outstanding (Diluted)
1,2771,2691,2701,2641,2611,2591,2591,2671,2931,2901,2871,2911,3191,3151,3211,3281,3361,3291,3271,322
Shares Change (YoY)
1.27%0.79%0.87%-0.24%-2.48%-2.40%-2.18%-1.86%-1.97%-1.90%-2.57%-2.79%-1.27%-1.05%-0.45%0.45%1.44%1.06%0.99%0.76%
EPS (Basic)
2.32-3.130.811.411.310.071.410.881.591.761.481.661.78-2.592.311.790.991.212.111.69
EPS (Diluted)
2.30-3.130.801.411.300.071.410.881.581.751.481.651.77-2.592.291.770.981.202.101.68
EPS Growth
76.92%--43.26%60.23%-17.72%-96.00%-4.73%-46.67%-10.73%--35.37%-6.78%80.61%-9.05%5.36%30.67%29.03%-7.08%9.80%
Free Cash Flow
2,606981,2903,8131,092-1,4152,4514,198-3,5472,1715,3176,454-2,6408,5435,0352,5123,4084,9135,3612,063
Free Cash Flow Growth
138.64%--47.37%-9.17%---53.90%-34.96%--74.59%5.60%156.93%-73.89%-6.08%21.76%19.41%266.64%-19.64%-19.51%
Free Cash Flow Per Share
2.040.081.023.020.87-1.121.953.31-2.741.684.135.00-2.006.503.811.892.553.704.041.56
Dividends Per Share
0.6650.6650.6650.6650.6650.6650.6650.6650.6050.6050.6050.6050.5500.5500.5500.5500.5000.5000.5000.500
Dividend Growth
----9.92%9.92%9.92%9.92%10.00%10.00%10.00%10.00%10.00%10.00%10.00%10.00%----
Gross Margin
12.84%13.42%13.74%15.22%13.20%13.16%14.67%14.20%14.79%15.13%15.30%15.68%16.53%16.50%17.18%17.43%17.92%17.21%18.17%18.09%
Operating Margin
2.00%-3.12%2.41%3.57%2.42%0.87%3.34%2.57%3.60%4.11%3.64%4.04%4.32%-4.83%5.79%4.61%3.06%4.15%5.96%5.18%
Profit Margin
2.77%-3.88%1.02%1.88%1.66%0.07%1.94%1.27%2.18%2.52%2.15%2.51%2.78%-4.19%3.77%3.07%1.81%2.15%3.84%3.22%
FCF Margin
2.47%0.10%1.30%4.03%1.12%-1.48%2.69%4.75%-3.78%2.42%5.98%7.57%-3.15%10.53%6.24%3.27%4.45%6.66%7.38%2.99%
EBITDA
3,259-3,2072,3814,5283,5158323,0453,4094,5074,8174,3384,4474,661-3,9194,6694,5942,3463,0614,3264,703
EBITDA Margin
3.08%-3.12%2.41%4.79%3.60%0.87%3.34%3.85%4.80%5.37%4.88%5.21%5.56%-4.83%5.79%5.98%3.06%4.15%5.96%6.81%
EBIT
2,112-3,2072,3813,3742,3688323,0452,2713,3733,6903,2343,4463,618-3,9194,6693,5452,3463,0614,3263,577
EBIT Margin
2.00%-3.12%2.41%3.57%2.42%0.87%3.34%2.57%3.60%4.11%3.64%4.04%4.32%-4.83%5.79%4.61%3.06%4.15%5.96%5.18%
Effective Tax Rate
-115.88%-14.59%38.49%31.91%23.66%32.38%24.35%28.86%24.33%24.98%25.53%25.60%25.97%23.51%26.40%21.53%17.78%26.01%25.27%25.12%
Updated Feb 10, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q